MedPath

Holger Joswig

🇩🇪Germany
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:0
Completed:2

Trial Phases

1 Phases

Not Applicable:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Not Applicable
1 (100.0%)

The Pathogenesis of Terson Syndrome and the Role of CSF Tau / Amyloid-ß 40 and 42 in Patients With Aneurysmatic Subarachnoid Hemorrhage

Completed
Conditions
Terson Syndrome
CSF-proteines
Subarachnoid Hemorrhage
First Posted Date
2014-05-01
Last Posted Date
2016-03-08
Lead Sponsor
Holger Joswig
Target Recruit Count
120
Registration Number
NCT02129010
Locations
🇨🇭

Cantonal Hospital St. Gallen, St. Gallen, Switzerland

The Value of Short-term Pain Relief for the Prediction of Long-term Outcome After Cervical or Lumbar Nerve Root Infiltration

Not Applicable
Completed
Conditions
Cervical Disc Herniation
Lumbar Disc Herniation
Interventions
Procedure: Lumbar nerve root infiltration
Procedure: Cervical nerve root infiltration
Drug: Mephamesone
First Posted Date
2013-09-18
Last Posted Date
2018-01-25
Lead Sponsor
Holger Joswig
Target Recruit Count
250
Registration Number
NCT01945554
Locations
🇨🇭

Flawil Hospital, Flawil, Saint Gallen, Switzerland

🇨🇭

Rorschach Hospital, Rorschach, Saint Gallen, Switzerland

🇨🇭

Cantonal Hospital St. Gallen, St. Gallen, Switzerland

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.